Back to JANX
Janus Henderson Group Ltd. → JANX
Janus Henderson Group Ltd. JANX Position History
Janux Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$287K
Q3 2026
Peak value
$72.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $112K |
| Q4 2025 | $1.3M |
| Q4 2025 | $72.4M |
| Q1 2026 | $57.9M |
| Q1 2026 | $430K |
| Q1 2026 | $57.9M |
| Q1 2026 | $430K |
| Q3 2026 | $5K |
| Q3 2026 | $287K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $287K | 16.6K | — | — |
| Q3 2026 | $5K | 314 | — | — |
| Q1 2026 | $430K | 31.0K | — | — |
| Q1 2026 | $57.9M | 4.17M | — | — |
| Q1 2026 | $430K | 31.0K | — | — |
| Q1 2026 | $57.9M | 4.17M | — | — |
| Q4 2025 | $72.4M | 5.25M | — | — |
| Q4 2025 | $1.3M | 97.0K | — | — |
| Q4 2025 | $112K | 8.1K | — | — |
Other funds holding JANX
$345.1M
$264.1M
$242.9M
$218.5M
$193.4M
$171.9M
$171.5M
$156M